Fundz

Daance.ai raised $2.6 million in pre-seed funding to develop AI technology for diagnosing and monitoring Parkinson’s Disease.

PRIVATENov 21, 2024

Amount Raised

$2.6 Million

Round Type

Pre-Seed

BostonBiotechnologyHealth Care

Description

Daance.ai emerged from stealth on Thursday with $2.6 million in pre-seed funding. The Cambridge-based startup aims to revolutionize the diagnosis and monitoring of movement disorders using artificial intelligence.

Quick answer

DANNCE.ai raised $2.6 Million in a Pre-Seed round, dated November 21, 2024. DANNCE.ai is based in Boston, Massachusetts, United States.

How much did DANNCE.ai raise?
DANNCE.ai raised $2.6 Million in a Pre-Seed round on November 21, 2024.
What does DANNCE.ai do?
DANNCE is a deep learning solution to automate behavioral analysis for drug development and disease diagnosis​.
Where is DANNCE.ai based and how big is it?
DANNCE.ai is based in Boston, Massachusetts, United States.
Who are the decision-makers at DANNCE.ai?
Fundz holds 1 contact at DANNCE.ai. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as DANNCE.ai that raised within 45 days of this round, from Fundz verified event records.

  • Carna raised $3.4M (Seed) on January 3, 2025.
  • Outset Medical raised $3.9M (Seed) on January 3, 2025.
  • General Proximity raised $16M (Seed) on January 3, 2025.
  • Botanic Healthcare raised $30M (Pre-Seed) on January 3, 2025.
  • Hinge Bio raised $31M on December 31, 2024.
  • Os Therapies raised $6M (Post-IPO Equity) on December 31, 2024.

Who to call at DANNCE.ai, and when

A new round usually means DANNCE.ai is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day DANNCE.ai raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at DANNCE.ai, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at DANNCE.ai. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

DANNCE.ai

Location

Boston, Massachusetts, United States

About

DANNCE is a deep learning solution to automate behavioral analysis for drug development and disease diagnosis​. Our platform takes patient video as input and uses our proprietary 3-D pose tracking and behavioral analysis algorithms to quantify behavior. DANNCE will help clinicians see the unseeable and drug developers generate real world evidence by using movement data and computer vision.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment DANNCE.ai raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for DANNCE.ai's next move

See what Strategic adds

DANNCE.ai raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.